HO-3867 is primarily studied for its potential applications in cancer therapy. It exhibits selective cytotoxicity towards cancer cells while sparing normal cells, making it a promising candidate for targeted cancer treatment. The compound is believed to induce apoptosis in cancer cells by disrupting cellular signaling pathways and promoting oxidative stress. Additionally, HO-3867 has shown anti-inflammatory properties, which could be beneficial in managing cancer-related inflammation and improving therapeutic outcomes. Research is ongoing to explore its efficacy in various cancer types and its potential use in combination with other chemotherapeutic agents to enhance treatment effectiveness.